Meeting | Topic: Better Management of “Off” Time with Parkinson’s | Speaker: Fahd Amjad, MD, MS
Dr. Fahd Amjad is Chief of Neurology at MedStar Montgomery Medical Center and an Assistant Professor of Neurology at Georgetown University Medical Center. He also serves as Co-Director of the Huntington Disease Care, Education, and Research Center at Georgetown. Dr. Amjad earned his medical degree from Georgetown University School of Medicine and completed his residency and fellowship training in neurology and movement disorders at Georgetown.
Board certified in neurology, Dr. Amjad specializes in the treatment of Parkinson’s disease, Huntington’s disease, dystonia, and neurogenic orthostatic hypotension. He has served as principal investigator for numerous clinical trials, including studies on levodopa-carbidopa intestinal gel and treatments for tardive dyskinesia.
Dr. Amjad is an active member of the American Academy of Neurology, the Movement Disorder Society, and the Parkinson Study Group, and frequently collaborates with pharmaceutical companies as a speaker and consultant.
The key take aways from the speaker and presentation will be:
- Understand the benefits and limitations of immediate release carbidopa/levadopa (IR CD/LD)
- Discuss what makes Crexont different from other forms of oral carbidopa/levadopa
- Learn how Crexont may help you get more “Good On” time with less frequent dosing compared to immediate release carbidopa/levadopa (IR CD/LD)
- Discover resources to help you start treatment with Crexont